NYSE: MOHMolina Healthcare Inc Stock
$352.30-15.11 (-4.11%)
Updated Apr 25, 2024
MOH Price
$352.30
Fair Value Price
N/A
Market Cap
$20.64B
52 Week Low
$266.35
52 Week High
$423.92
P/E
18.99x
P/B
4.59x
P/S
0.67x
PEG
0.9x
Dividend Yield
N/A
Revenue
$35.85B
Earnings
$1.07B
Gross Margin
12.4%
Operating Margin
4.31%
Profit Margin
3%
Debt to Equity
2.45
Operating Cash Flow
$960M
Beta
0.83
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
MOH Overview
Molina Healthcare Incorporated provides Medicare Advantage plans free of cost to address the healthcare requirements of individuals with Medicare or both Medicaid and Medicare coverage. It also provides marketplace plans to remove financial barriers and enable its Medicaid members to stay with their providers as they transition between Medicaid and the marketplace. Molina Healthcare was founded in 1980 and is headquartered in Long Beach, CA.
Zen Score
–
Industry Average (39)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MOH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MOH ($352.30) is trading above its intrinsic value of $238.59, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MOH is good value based on its earnings relative to its share price (18.99x), compared to the US market average (40.97x)
P/E vs Market Valuation
MOH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more MOH due diligence checks available for Premium users.
Be the first to know about important MOH news, forecast changes, insider trades & much more!
MOH News
Valuation
MOH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
18.99x
Industry
18.89x
Market
40.97x
MOH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MOH is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
MOH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.59x
Industry
2.93x
MOH is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MOH price to earnings growth (PEG)
For valuing profitable companies with growth potential
MOH is good value based... subscribe to Premium to read more.
PEG Value Valuation
MOH's financial health
Profit margin
Revenue
$9.9B
Net Income
$301.0M
Profit Margin
3%
MOH's Earnings (EBIT) of $1.54B... subscribe to Premium to read more.
Interest Coverage Financials
MOH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$15.5B
Liabilities
$11.0B
Debt to equity
2.45
MOH's short-term assets ($12.67B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MOH's short-term assets ($12.67B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MOH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MOH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$214.0M
Investing
-$488.0M
Financing
-$62.0M
MOH's operating cash flow ($960.00M)... subscribe to Premium to read more.
Debt Coverage Financials
MOH vs Healthcare Plan Stocks
Molina Healthcare Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.